Long
Updated

Trevena in for a bull run.

Waiting for the NDA resubmission news. Expecting the company presentation in 2020 BIO CEO & Investor Conference on Feb 11, 2020, to cause the market to move upward.
In a possible future FDA approval for their IV oliceridine drug will cause a nice Trend up. Holding all Longs and Share positions.
Trade active
snapshot

Support zone tested and retraced, still showing bullish signs.
Note
snapshot

Bullshit Flag next Target is 1.95

Disclaimer